Open Nav

Michael Byrnes

Chief Financial Officer

Alkahest, Inc.

Michael has over 20 years of corporate finance and accounting experience, 15 of which have been in publicly-traded companies in the life science industry. Most recently, Michael was the Chief Financial Officer of Ocera Therapeutics, which was acquired by Mallinckrodt Pharmaceuticals in 2017. Prior to that, Michael held finance positions of increasing responsibility at Maxygen, NeurogesX, Lipid Sciences and ADAC Labs. Michael received his B.S.C. in Finance from Santa Clara University and his M.B.A. from California State University, Hayward.

This speaker's sessions: